In early January 2021, travelers returning to Tokyo, Japan, from Amazonas, Brazil, were screened for COVID-19 at the airport. A few days later, the National Institute of Infectious Disease of Japan announced that the travelers had returned with a new variant of the SARS-CoV-2 virus.
That variant, known as gamma, or P.1, led to a deadly surge in COVID-19 cases in Brazil this spring, and has now spread across the world. More than 200 cases have been detected in Wisconsin. Whether current vaccines are as effective against the gamma variant remains unknown.
In a new study using variant virus recovered from one of the original travelers, researchers in the U.S. and Japan have found that vaccination with an mRNA vaccine induces antibody responses that would protect humans from infection with the gamma/P.1 variant. Hamsters previously infected with the virus strains first circulating in early 2020 were also protected from infection with the gamma variant nine months later.
The findings, the researchers say, suggest that previous SARS-CoV-2 infection and vaccines that are based on earlier strains of the virus still provide protection against infection with gamma. The study published in the Proceedings of the National Academy of Sciences on June 17, 2021.
The animals were quite protected, says study lead Yoshihiro Kawaoka, a professor of virology at the University of WisconsinMadison School of Veterinary Medicine and the University of Tokyo. There may be people who get infected with this variant even though they are vaccinated or were previously infected, but they shouldnt get severe disease.
However, he says, that is not consistent with what has been happening in Brazil, where there have been reports of people reinfected with the gamma variant after recovering from infection with an earlier strain. Its possible, Kawaoka says, that COVID-19 immunity lasts longer in hamsters than in humans, or that cases documented as reinfections are actually first infections.
Kawaokas research team established the Syrian hamster model for COVID-19 last year, after demonstrating that hamsters are highly susceptible to the SARS-CoV-2 virus and develop disease similar to humans, like ground glass opacity in their lungs. They also develop lasting antibodies that protect against reinfection.
Animal models are great because (they allow us to) test vaccines, test drugs, test monoclonal antibodies and even do pathogenesis (studies), says Kawaoka.
In fact, his team studied the gamma variant in hamsters because, while previous studies suggested P.1 might bind better to cells and resist antibodies created by previous infections or vaccination, little is known about the variants ability to replicate in the body, how much illness or pathogenesis it causes, or how well immune responses react to the virus.
The researchers infected hamsters with either the P.1/gamma variant isolated from the traveler, or with one of two earlier strains of the virus from human samples one isolated from a patient in February 2020, and the other from a patient with a non-variant globally predominant strain. Each of the strains replicated similarly in the nose and lungs of hamsters and caused similar illness affecting the lungs.
Next, Kawaokas team looked at whether antibodies in convalescent sera from 35 recovered COVID-19 patients or from people whod received the Pfizer-BioNTech mRNA vaccine could neutralize each of the three viral strains.
Following a natural infection or vaccination, the body produces antibodies that learn to recognize the spike protein of the SARS-CoV-2 virus, which is responsible for binding to cells. Should people encounter the virus again, antibodies recognize the spike protein and subsequently fight off or limit the extent of infection.
Earlier studies have shown that a spike protein mutation E484K, found in gamma variants can change the spike proteins identity just enough that the variant can slip past these defenses. However, antibodies in the blood of vaccinated individuals reacted to all three strains, including gamma.
Antibodies in the blood of recovered COVID-19 patients were also effective at neutralizing each of the strains. However, of the 35 patients, one had been infected with gamma and the antibodies from this individual were less reactive to the non-variant strains.
The researchers say these findings suggest there are some important differences in the spike protein of gamma that might influence immunity, warranting further monitoring. Additionally, Kawaokas group found that gamma, but not other strains of SARS-CoV-2, can infect and replicate in mice, suggesting that the spike protein interacts differently with cells than earlier strains.
The researchers also found that hamsters that had recovered from infection with either of the earlier strains of SARS-CoV-2 were protected against viral replication in their lungs if reinfected with either the same strain or the gamma variant, three weeks and nine months later.
However, gamma was recovered in the nasal passages of reinfected animals in both groups. The amount of virus in the nasal passages of reinfected animals was 1,000-fold lower than animals infected for the first time.
Finally, the researchers studied whether convalescent plasma from three patients infected with SARS-CoV-2 in early 2020 could protect against viral replication in the nose and lungs of hamsters. They found that convalescent plasma, but not plasma from patients who did not have COVID-19, limited virus replication in the lungs of hamsters infected with the prevailing non-variant strain and with gamma/P.1. Virus was found in their nasal passages.
Vaccination, Kawaoka says, is the best way to seek protection from SARS-CoV-2 and emerging variants, including the delta variant, also known as B.1.617.2. The Centers for Disease Control and Prevention recently designated the delta version as a variant of concern due to evidence that it transmits more readily.
Peter Halfmann, research associate professor at UWMadison and co-leader of the study, added that the gamma and delta variants are circulating in Madison and other parts of the U.S., highlighting the importance of vaccination.
The difference between the original strain and (delta) and the original strain and (gamma) is similar, Kawaoka adds, noting: The (delta) variant may become prevalent but it shouldnt be extremely concerning as long as you are vaccinated.
With SARS-CoV-2 changing as it spreads, some versions of the virus will disappear as new variants emerge, as happened with a European variant in early 2020 that quickly eclipsed the original virus first found in China.
At least in the vast majority of the population, we dont have good immunity to SARS-CoV-2, so the selective pressure on the virus at the moment is transmissibility, Kawaoka says, explaining why new variants that successfully spread tend to be more transmissible than those that came before. But it will change. We should expect to see the selective pressure become immunity.
This is why vaccines will likely need to be modified in the coming years, he explains, in order to protect against a virus that will evolve to evade the protections we devise so long as spread of the virus remains high, or if our immune systems dont maintain defenses for long enough to prevent reinfections.
We dont know which one is going to be the case its too early to say how long immunity to this virus lasts, he says. Hamsters look different from humans, anyway. Its difficult to predict.
Peter Halfmann, a research associate professor at UWMadison, and Masaki Imai in the Division of Virology at the University of Tokyo, co-led the study.
It was supported by a Research Program on Emerging andRe-emerging Infectious Diseases (JP19fk0108113, JP19fk0108166, JP20fk0108412, and JP21fk0108104;, a Project Promoting Support for Drug Discovery (JP20nk0101612, JP20nk0101614, and JP20nk0101603); the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) (JP19fm0108006); the Japan Program for Infectious Diseases Research and Infrastructure (JP20wm0125002 and 20fk0108272) from the Japan Agency for Medical Research and Development (AMED); the National Institutes of Allergy and Infectious Diseases funded Center for Research on Influenza Pathogenesis (CRIP; HHSN272201400008C); the Wisconsin National Primate Research Center (P51OD011106), and the Collaborative Influenza Vaccine Innovation Center (CIVIC; 75N93019C00051).
See the article here:
Vaccination, previous infection, protect against COVID-19 gamma/P.1 variant in animal model - University of Wisconsin-Madison
- USF epidemiologist: vaccination rate must double to slow transmission of COVID-19 - University of South Florida - July 24th, 2021
- Making waves in India: Media and the COVID-19 pandemic - Brookings Institution - July 24th, 2021
- COVID-19 cases increasing in King County: Vaccination continues to be our best protection - Public Health Insider - July 24th, 2021
- COVID-19 Daily Update 7-23-2021 - West Virginia Department of Health and Human Resources - July 24th, 2021
- New Zealand Suspends Travel Bubble With Australia As Sydney COVID-19 Cluster Grows - NPR - July 24th, 2021
- COVID-19: Are lockdowns worse than the disease? - Medical News Today - July 24th, 2021
- Alaska's COVID-19 surge continues with 447 cases, 2 deaths and rising hospitalizations reported Thursday and Friday - Anchorage Daily News - July 24th, 2021
- Oregon firefighters face return of hazardous conditions, COVID-19 outbreak - Reuters - July 24th, 2021
- We have vaccines. Did the Covid-19 Olympics have to be a mess? - Vox.com - July 24th, 2021
- Early COVID-19 responses in the nose and throat predict disease severity - Boston Children's Answers - Boston Children's Discoveries - July 24th, 2021
- Delta variant in Indiana: What you need to know about COVID-19 variant - IndyStar - July 24th, 2021
- COVID-19 town hall preps parents for return to school - The Mercury - July 24th, 2021
- Mayor Bowser and DC Health Release the District of Columbia COVID-19 Pandemic Health and Healthcare Recovery Report | mayormb - Executive Office of... - July 24th, 2021
- Breakthrough infection: Fully-vaccinated Struthers woman still contracted COVID-19 - WKBN.com - July 24th, 2021
- 1,000+ breakthrough cases of COVID-19 reported in Tennessee - WKRN News 2 - July 24th, 2021
- Illinois reports 7,983 new cases of COVID-19, 47 deaths over past week - WGN TV Chicago - July 24th, 2021
- Indias Covid-19 Death Toll Is Likely in the Millions, Study Finds - The Wall Street Journal - July 24th, 2021
- With Tokyo 2020 overshadowed by Covid-19, athletes are left to bring light to troubled Olympics - CNN - July 24th, 2021
- Gauteng launches COVID-19 vaccination drive-thru - SABC ... - July 22nd, 2021
- Grave concern: Gauteng prepares cemeteries as Covid-19 ... - July 22nd, 2021
- COVID-19: New maps expose Gauteng's worst hot-spots [photo] - July 22nd, 2021
- Texas has seen nearly 9000 COVID-19 deaths since February. All but 43 were unvaccinated people. - The Texas Tribune - July 22nd, 2021
- How Nations Are Learning to Live With Covid-19 Pandemic - The New York Times - July 22nd, 2021
- When will COVID-19 vaccines be fully approvedand does it matter whether they are? - Science Magazine - July 22nd, 2021
- Louisiana Hits Third-Highest Number Of COVID-19 Cases Reported In A Day - WWNO - July 22nd, 2021
- CBJ reports 29 new COVID-19 cases in Juneau July 20 & 21 City and Borough of Juneau - City and Borough of Juneau - July 22nd, 2021
- Who is providing COVID-19 care in the Washington Metropolitan Area? - The D.C. Policy Center - July 22nd, 2021
- COVID-19: What you need to know about the pandemic on 21 July - World Economic Forum - July 22nd, 2021
- COVID-19 cases going up in Oregon as number of people getting vaccinated drops - OPB News - July 22nd, 2021
- COVID Vaccines And Infertility? How Misinformation Spreads In 6 Steps : Shots - Health News - NPR - July 22nd, 2021
- Inslee rescinds three proclamations related to the COVID-19 pandemic | Governor Jay Inslee - Governor Jay Inslee - July 22nd, 2021
- Cape Cod COVID-19 cluster grows to more than 130 infected, prompting renewed mitigation efforts - ABC News - July 22nd, 2021
- COVID-19 Vaccine Success Could Be Measured With One Number - The Atlantic - July 22nd, 2021
- Delta Variant of Covid-19 Isnt Expected to Dent Robust U.S. Recovery - The Wall Street Journal - July 22nd, 2021
- How Universities Are Preparing for Another School Year Amid COVID-19 - WTTW News - July 22nd, 2021
- COVID-19: How can the air quality in India be improved? | World Economic Forum - World Economic Forum - July 22nd, 2021
- US extends Covid-19 travel restrictions with Canada and Mexico through August 21 - CNN - July 22nd, 2021
- Covid-19 'is becoming a pandemic of the unvaccinated,' CDC director says - CNN - July 20th, 2021
- Southeast Asian Countries Struggle To Contain A Devastating Third Wave Of COVID-19 - NPR - July 20th, 2021
- Covid-19 breakthrough infections are preventable, but it's going to take a big effort to stop them - CNN - July 20th, 2021
- Costco reverses course and will keep senior hours as COVID-19 cases increase nationwide - USA TODAY - July 20th, 2021
- U.S. Womens Gymnastics Alternate Tests Positive for Covid-19 at Tokyo Olympics - The Wall Street Journal - July 20th, 2021
- Olympics and Covid-19 pandemic: Live updates - CNN - July 20th, 2021
- ALERT: Uncontrolled COVID-19 spread reported in Williamson County - KXAN.com - July 20th, 2021
- Five Texas House Democrats test positive for Covid-19 in Washington - CNN - July 20th, 2021
- Austin area may see over 12,000 COVID-19 hospitalizations before October, UT projections show - KXAN.com - July 20th, 2021
- How Delta is pushing the US into a new phase of the Covid-19 pandemic - STAT - July 20th, 2021
- Baker-Polito Administration to Invest $186 Million in Federal COVID-19 Funding for Critical Health Care and Workforce Priorities - Mass.gov - July 20th, 2021
- COVID-19: What you need to know about the coronavirus pandemic on 19 July - World Economic Forum - July 20th, 2021
- NEW: Nevadas COVID-19 hospitalizations, cases soar as state hits 12% test positivity over the weekend - KLAS - 8 News Now - July 20th, 2021
- COVID-19 cases may cause an S&P 500 correction, analyst says. Buy these stocks in the next dip. - MarketWatch - July 20th, 2021
- VB health department hosting COVID-19 vaccine clinic on Wednesday, July 21 - WAVY.com - July 20th, 2021
- U.S. Covid-19 Case Counts Have Doubled in Recent Weeks - The Wall Street Journal - July 20th, 2021
- Insurer Filings Suggest COVID-19 Pandemic Will Not Drive Health Spending In 2022 - Kaiser Family Foundation - July 20th, 2021
- Vaccinated U.K. Health Secretary Tests Positive For COVID-19 - NPR - July 18th, 2021
- Music banned on Greece's Mykonos in new COVID-19 restrictions - Reuters - July 18th, 2021
- With Startling Surge in COVID-19 Cases Among the Unvaccinated, Gov. John Bel Edwards Encourages All Louisianans to Take Precautions - Governor John... - July 18th, 2021
- Niger Is the Land That Covid-19 Forgot - The Wall Street Journal - July 18th, 2021
- A small percentage of Alaska's COVID-19 cases have involved fully vaccinated people. Here's what we know so far. - KTOO - July 18th, 2021
- All adults in Britain offered a COVID-19 shot ahead of Monday reopening - Reuters UK - July 18th, 2021
- 154 Norovirus Outbreaks In England As Covid-19 Precautions Relaxed - Forbes - July 18th, 2021
- 'Just trying to keep it together': Springfield nurses frustrated as COVID-19 surges - News-Leader - July 18th, 2021
- From dancing to delta variant: One Austin mans COVID-19 battle and the message from his loved ones - KXAN.com - July 18th, 2021
- Louisiana Department of Health announces COVID-19 testing for week of July 19-25 | Department of Health | State of Louisiana - Louisiana Department of... - July 18th, 2021
- Georgia rugby coach on ventilator with COVID-19 in SAfrica - Associated Press - July 18th, 2021
- Here's How Well COVID-19 Vaccines Work Against the Delta Variant - Healthline - July 18th, 2021
- As COVID-19 surges again, what experts say about the millions of unvaccinated - ABC News - July 18th, 2021
- Yankees Add Aaron Judge and Two Others to Covid-19 Injured List - The New York Times - July 18th, 2021
- Clues to Covid-19s Origins Include Anonymous Skin Sample in Italy - The Wall Street Journal - July 18th, 2021
- COVID-19: Customer Information | Eastern Bank - July 15th, 2021
- 3 Things You Need to Know About the Delta Variant - COVID-19, Featured, Health Topics - Hackensack Meridian Health - July 15th, 2021
- COVID-19 Daily Update 7-15-2021 - West Virginia Department of Health and Human Resources - July 15th, 2021
- Massachusetts COVID-19 Relief Fund | Eastern Bank - July 15th, 2021
- Study finds physicians are widely effective messengers of Covid-19 information - MIT News - July 15th, 2021
- COVID-19 Delta variant could be to blame for recent breakthrough cases in fully vaccinated people - ABC Action News - July 15th, 2021
- CBJ reports nine new COVID-19 cases in Juneau July 13 & 14 City and Borough of Juneau - City and Borough of Juneau - July 15th, 2021
- COVID-19: What you need to know about the coronavirus pandemic on 15 July - World Economic Forum - July 15th, 2021
- COVID-19 pandemic leads to major backsliding on childhood vaccinations, new WHO - UNICEF - July 15th, 2021
- U.S. COVID-19 cases more than double in two weeks as delta variant spreads fast, and WHO warns 'pandemic nowhere near finished' - MarketWatch - July 15th, 2021
- Nearly in tears of disbelief: Central Texans share experiences of getting COVID-19 even after vaccination - KXAN.com - July 15th, 2021